For the Inventor, By the Inventor

Enter assignee name

Rockville, MD, United States of America

Sanaria Inc.

USPTO Granted Patents = 26

% Expired Patents = 7.7

CIPO Patents = 1

EPO Patents = 6

Trademarks = 1

Forward Citations = 138

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Stephen L Hoffman (22 out of 34 patents)

B Kim Lee Sim (8 out of 11 patents)

Richard E Stafford (7 out of 8 patents)

4. Minglin Li (7 out of 7 patents)

5. Abraham G Eappen (5 out of 5 patents)

6. Sumana Chakravarty (4 out of 4 patents)

7. Robert Seder (3 out of 9 patents)

8. Eric R James (3 out of 3 patents)

9. Russell H Taylor (2 out of 85 patents)

10. Iulian Ioan Iordachita (2 out of 23 patents)

11. Neville Kisalu (2 out of 2 patents)

12. Azza Idris (2 out of 2 patents)

13. Barbara Flynn (2 out of 2 patents)

14. Gregory Chirikjian (2 out of 7 patents)

15. Moriya Tsuji (2 out of 13 patents)

Core Competencies:

Cryogenic Storage

Mosquito Egg Cryopreservation

Live Attenuated Vaccine

Plasmodium Sporozoites

Neutralizing Antibodies

Automated Extraction Device

Serum Antibody Assay

Genetic Attenuation

Vaccine Compositions

Haematophagous Organisms

26 patents: Sort by Forward Citations

1. 12528084 - Container and cap assembly for cryogenic storage (2026-01-20),

2. 12484575 - Mosquito egg cryopreservation (2025-12-02),

3. 12409213 - Live attenuated oral vaccine against shigellosis and typhoid fever (2025-09-09),

4. 12171822 - Infectious plasmodium sporozoites grown in vitro (2024-12-24),

5. 11883475 - Infectioussporozoites grown in vitro (2024-01-30),

6. 11760794 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2023-09-19),

7. 11503819 - Apparatus and method of use for an automated mosquito salivary gland extraction device (2022-11-22),

8. 11207395 - Infectious plasmodium sporozoites grown in vitro (2021-12-28),

9. 11021535 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2021-06-01),

10. 10995980 - Cryovial storage system (2021-05-04),

11. 10781419 - Mosquito salivary gland extraction device and methods of use (2020-09-22),

12. 10441646 - Infectious plasmodium sporozoites grown in vitro (2019-10-15),

13. 10272146 - Purified plasmodium and vaccine compositions (2019-04-30),

14. 10197577 - Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines (2019-02-05),

15. 9931389 - Genetic attenuation of plasmodium by B9 gene disruption (2018-04-03),

Sanaria Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of innovative malaria vaccines. The organization focuses on harnessing advanced research in immunology and vaccine technology to create effective solutions for malaria prevention. Sanaria's proprietary platform aims to provide a safe and efficacious vaccine that can significantly reduce the global burden of malaria, a disease that continues to impact millions worldwide. Through its commitment to scientific excellence, Sanaria is positioned at the forefront of malaria vaccine development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

26 Patents

#28 in Rockville, MD

#161 in Maryland

#12,843 in US

#24,758 in the World

Rockville, MD, United States of America

Sanaria Inc.

Forward Citations = 138

44 inventors:

Stephen L Hoffman (22 out of 34 patents)

B Kim Lee Sim (8 out of 11 patents)

Richard E Stafford (7 out of 8 patents)

4. Minglin Li (7 out of 7 patents)

5. Abraham G Eappen (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…